app-store-icon play-store-icon
Apr-Jun Earnings: Cipla Apr-Jun consol PAT rises to INR 12.98 bln from INR 11.78 bln year ago

Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.

Please register for a 30-day free trial. Click here
Apr-Jun Earnings

Cipla Apr-Jun consol PAT rises to INR 12.98 bln from INR 11.78 bln year ago

This story was originally published at 13:36 IST on July 25, 2025  Back
Register to read our real-time news.

Informist, Friday, Jul. 25, 2025

MUMBAI - Cipla Ltd.’s consolidated net profit for Apr-Jun rose to INR 12.98 billion from INR 11.78 billion year ago. The bottom line was also higher than the analyst estimate of INR 12.29 billion. The company’s revenue for the quarter rose to INR 69.57 billion from INR 66.94 billion year ago. Revenue from the pharmaceutical operations rose to INR 65.79 billion from INR 63.89 billion a year ago.

* Cipla Apr-Jun consol net profit INR 12.98 bln
* Analysts saw Cipla Apr-Jun consol net profit at INR 12.29 bln
* Cipla Apr-Jun consol net profit INR 12.98 bln vs INR 11.78 bln year ago
* Cipla Apr-Jun consol revenue INR 69.57 bln vs INR 66.94 bln year ago
* Cipla Apr-Jun consol pharma revenue INR 65.79 bln vs INR 63.89 bln year ago